中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

232 records (took 0.022 seconds)

    NEW ANTIBIOTIC SUBSTANCE FEGLYMYCIN, ITS PRODUCTION AND USE
    1.
    发明专利
    NEW ANTIBIOTIC SUBSTANCE FEGLYMYCIN, ITS PRODUCTION AND USE 失效

    公开(公告)号：JPH10204099A

    公开(公告)日：1998-08-04

    申请号：JP34263197

    申请日：1997-12-12

    Applicant: HOECHST AG

    Inventor： VERTESY LASZLO ,  KNAUF MARTIN ,  WINK JOACHIM ,  ISERT DIETER ,  STAHL WILHELM ,  RIESS GUNTHER ,  ASZODI JOZSEF ,  BELLER DOMINIQUE LE

    IPC: C12P1/06 ,  A61K38/00 ,  A61K38/10 ,  A61P31/00 ,  C07K7/08 ,  C12N1/20 ,  C12P21/02 ,  C12R1/465 ,  C12R1/645

    Abstract: PROBLEM TO BE SOLVED: To provide the subject new non-toxic substance produced by a specific microorganism of the genus Streptomyces, active as an antibiotic substance, having high tolerance and effectively inhibiting human immunodeficiency virus. SOLUTION: This substance is a compound of the formula, its salt or its chemically equivalent substance. It has the following properties. Appearance, colorless; solubility, soluble in methanol, acetonitrile and water; stability, stable under neutral or moderately alkaline conditions and unstable in strongly acidic or strongly alkaline solution; molecular formula, C95 H97 N13 O30 ; molecular weight, 1900.90; etc. The compound can be produced by the fermentation with a microorganism HAG 4674 (DSM 11171) of the genus Streptomyces, its variant or mutant. The fermentation is preferably carried out in a nutrient solution containing 1-2% of oat flake and a minor element solution of 0.2-0.3% concentration under aerobic condition at 25-30 deg.C and pH5.5-8.5 for 24-140hr.

    NEW POLYENE ANTIBIOTIC SUBSTANCE 3874H1 TO H6, THEIR PRODUCTION AND USE THEREOF
    2.
    发明专利
    NEW POLYENE ANTIBIOTIC SUBSTANCE 3874H1 TO H6, THEIR PRODUCTION AND USE THEREOF 失效

    公开(公告)号：JPH10120686A

    公开(公告)日：1998-05-12

    申请号：JP22225897

    申请日：1997-08-19

    Applicant: HOECHST AG

    Inventor： VERTESY LASZLO ,  KURZ MICHAEL ,  WINK JOACHIM ,  MARKUS ASTRID ,  STAHL WILHELM

    IPC: C12P17/18 ,  A61K31/365 ,  A61P31/04 ,  A61P31/10 ,  A61P33/02 ,  C07D493/04 ,  C07H17/08 ,  C12N1/20 ,  C12P19/62 ,  C12R1/465

    Abstract: PROBLEM TO BE SOLVED: To obtain a novel polyene antibiotic substances 3874H1 to H6 which are produced by Streptomyces DSM11007 and is useful as an antifungal agent of a therapeutic agent for treatment of diseases relating to increased steroidal concentration. SOLUTION: This novel polyene antibiotic agent is produced by Streptomyces DSM11007 and comprises the following 6 substances: antibiotic substance 3874H1 is represented by formula I, has the molecular formula of C58 H86 N2 O18 and the molecular weight of 1099.3; the antibiotic substance 3874H2 is represented by formula II, has the molecular formula of C59 H88 N2 O18 and the molecular weight of 1113.3; the antibiotic substance 3874H3 is represented by formula III, has the molecular formula of C57 H87 N2 O18 and the molecular weight of 1074.3; the antibiotic substance 3874H4 is represented by formula IV, has the molecular formula of C58 H84 N2 O18 and the molecular weight of 1097.3; the antibiotic substance 3874H5 is represented by formula V, has the molecular formula of C57 H85 N2 O18 and the molecular weight of 1072.3. The agent is useful as an antifungal agent and for treatment of diseases relating to increased steroidalal concentration. These antibiotic substances are obtained by fermentation of Streptomyces DSM11007 or its mutant under appropriate conditions and isolating the products from the culture mixture, respectively.

    10.
    发明专利
    未知

    公开(公告)号：PT92757B

    公开(公告)日：1995-12-29

    申请号：PT9275789

    申请日：1989-12-28

    Applicant: HOECHST AG

    Inventor： VERTESY LASZLO ,  GEISEN KARL ,  RIESS GUNTHER JOHANNES ,  SAUBER KLAUS

    IPC: C12P21/02 ,  A61K38/00 ,  A61K38/28 ,  A61P3/08 ,  A61P3/10 ,  C07H21/04 ,  C07K1/06 ,  C07K1/08 ,  C07K1/20 ,  C07K14/575 ,  C07K14/62 ,  C12N15/09 ,  C12R1/19 ,  C12R1/465

    Abstract: Insulin derivatives with a basic modification owing to the basic amino acid arginine in position A0 of the formula II in which a) R + R together = OH or b) R = residue of a neutral, genetically encodable L-amino acid and R = OH or a physiologically acceptable organic group which is basic in nature and has up to 50 C atoms, in whose structure 0 to 3 alpha -amino acids are involved and whose terminal carboxyl group, which is present where appropriate, can be free, as ester function, as amide function, as lactone or reduced to CH2OH, with the exception of the case in which, at the same time, R = Ala, R = OH and the A and B chain are the sequences of bovine insulin, and the physiologically tolerated salts thereof are obtained by various processes. The compounds are suitable for the treatment of diabetes mellitus, have a delayed profile of action and are very well tolerated.

Patent Agency Ranking